Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
311.66
303.08
339.22
304.22
281.21
250.53
171.09
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
311.66
303.08
339.22
304.22
281.21
250.53
171.09
Raw Material Cost
160.97
149.89
181.58
179.19
163.99
135.47
72.20
Purchase of Finished goods
9.23
15.06
11.24
11.45
8.43
10.43
8.21
(Increase) / Decrease In Stocks
-12.23
-7.05
-1.06
-17.87
-4.89
5.05
3.38
Employee Cost
66.46
62.40
60.48
54.95
47.25
41.88
50.43
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
-0.01
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
55.33
53.23
56.24
51.10
42.96
33.24
32.11
Total Expenditure (Excl Depreciation)
279.76
273.52
308.47
278.82
257.74
226.07
166.33
Operating Profit (PBDIT) excl Other Income
31.90
29.56
30.75
25.40
23.47
24.46
4.76
Other Income
1.93
2.20
2.85
0.98
5.15
1.14
1.84
Operating Profit (PBDIT)
33.83
31.76
33.60
26.38
28.62
25.60
6.60
Interest
16.82
16.85
14.48
12.49
10.41
11.97
12.45
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
17.01
14.91
19.12
13.89
18.21
13.63
-5.85
Depreciation
11.08
9.77
10.07
9.13
9.04
9.52
7.68
Profit Before Tax
5.93
5.14
9.05
4.75
9.18
4.10
-13.53
Tax
-0.39
-2.10
1.60
2.13
3.48
-0.61
-0.64
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
6.32
7.24
7.45
2.62
5.70
4.71
-12.89
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
6.32
7.24
7.45
2.62
5.70
4.71
-12.89
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.04
-0.02
-0.05
-0.05
-0.09
0.03
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
6.28
7.22
7.39
2.57
5.61
4.74
-12.89
Equity Capital
15.92
15.92
15.80
15.69
14.82
14.82
14.17
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
66.31
61.50
53.69
48.10
43.80
38.76
38.25
Earnings per share (EPS)
3.94
4.54
4.68
1.64
3.79
3.2
-9.1
Diluted Earnings per share
3.95
4.56
4.96
1.68
3.71
3.34
-9.1
Operating Profit Margin (Excl OI)
10.24%
9.75%
9.06%
8.35%
8.35%
9.76%
2.78%
Gross Profit Margin
5.46%
4.92%
5.64%
4.57%
6.48%
5.44%
-3.42%
PAT Margin
2.03%
2.39%
2.2%
0.86%
2.03%
1.88%
-7.53%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 2.83% vs -10.65% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is -13.02% vs -2.30% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 7.92% vs -3.87% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -0.18% vs 16.37% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Bal Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
311.66
0
311.66
Other Operating Income
0.00
0.00
0.00
Total Operating income
311.66
0
311.66
Raw Material Cost
160.97
0
160.97
Purchase of Finished goods
9.23
0
9.23
(Increase) / Decrease In Stocks
-12.23
0
-12.23
Employee Cost
66.46
0
66.46
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
55.33
0.00
55.33
Total Expenditure (Excl Depreciation)
279.76
0
279.76
Operating Profit (PBDIT) excl Other Income
31.90
0.00
31.90
Other Income
1.93
0
1.93
Operating Profit (PBDIT)
33.83
0
33.83
Interest
16.82
0
16.82
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
17.01
0
17.01
Depreciation
11.08
0
11.08
Profit Before Tax
5.93
0
5.93
Tax
-0.39
0
-0.39
Provisions and contingencies
0.00
0
0.00
Profit After Tax
6.32
0
6.32
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
6.32
0
6.32
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.04
0
-0.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6.28
0
6.28
Equity Capital
15.92
0
15.92
Face Value
10.00
0
0.00
Reserves
66.31
0
66.31
Earnings per share (EPS)
3.94
0
3.94
Diluted Earnings per share
3.95
0
3.95
Operating Profit Margin (Excl OI)
10.24%
0%
0.00
10.24%
Gross Profit Margin
5.46%
0%
0.00
5.46%
PAT Margin
2.03%
0%
0.00
2.03%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 311.66 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 2.83% vs -10.65% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 6.28 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -13.02% vs -2.30% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 31.90 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.92% vs -3.87% in Mar 2025
Annual - Interest
Interest 16.82 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -0.18% vs 16.37% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.24%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
